Aphios Corp

North Reading, MA Doing business as Aphios Corp Research And Development

UEI
HDE2J1H521A7
CAGE
06PV8
Primary NAICS
541690 Other Scientific and Technical Consulting Services
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Minority Owned Business
  • For Profit Organization
  • Black American Owned
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
87 Main St, North Reading, MA 01864, USA
Website
aphios.com
Founded
1993
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

About Aphios Corp

Aphios Corp is a minority-owned biotechnology research and development company located in North Reading, Massachusetts, focusing on advanced drug delivery technologies and innovative therapeutic development. Registered in SAM.gov since June 20, 2001, the company specializes in developing sophisticated pharmaceutical and biotechnological solutions across multiple medical domains. The organization is structured as a for-profit, black American-owned corporate entity that has demonstrated significant capability in translating complex scientific research into potential medical innovations.

Through recent federal grant awards, Aphios Corp has pursued groundbreaking research in several critical medical areas, including neurological disorders, cancer treatment support, addiction management, and infectious disease prevention. The company has secured project grants from prominent federal agencies such as the National Center for Complementary and Integrative Health, National Institute on Aging, National Institute on Drug Abuse, and National Institute of Allergy and Infectious Diseases. Their research portfolio includes developing a botanical drug for chemotherapy-induced nausea and vomiting (ZINDOL), creating targeted nanoparticle therapeutics for Alzheimer's disease, formulating an extended-release combination treatment for opioid use disorder, and engineering a novel double-encapsulated mRNA vaccine for COVID-19. Each project involves sophisticated drug delivery technologies, including nanoencapsulation techniques, with a focus on improving drug efficacy, reducing side effects, and creating more patient-friendly treatment modalities across various medical conditions.

Quick answers

What is Aphios Corp's UEI?

Aphios Corp's Unique Entity ID (UEI) in SAM.gov is HDE2J1H521A7.

What is Aphios Corp's CAGE code?

Aphios Corp's CAGE code is 06PV8.

What is Aphios Corp's primary NAICS code?

Aphios Corp's primary NAICS code is 541690 (Other Scientific and Technical Consulting Services).

Where is Aphios Corp located?

Aphios Corp's physical address in SAM.gov is 87 Main St, North Reading, MA 01864, USA.

Is Aphios Corp registered in SAM.gov?

Yes. Aphios Corp's SAM.gov registration is active through December 22, 2026.

What is Aphios Corp's most recent federal award?

Aphios Corp's most recent federal grant award is Botanical drug for chemotherapy induced nausea and vomiting - project summary nausea and vomiting are among the most… (R43AT013554), from National Center for Complementary and Integrative Health, on September 1, 2025.

On GovTribe

See Aphios Corp's full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors